Tag:
Lumavita
Latest Headlines
Latest Headlines
Lumavita adds $5.5M to Series A
Swiss biotech company Lumavita has tacked on an additional CHF6m ($5.53 million) to a Series A round initiated in September 2008. New investor HealthCap and existing investor Endeavour Vision
Peplin gains $24M to fund Phase III
Australian transplant Peplin has rounded up $24 million and two new top executives. New Enterprise Associates, MPM Capital, and two Australian investors put up the money. Peplin relocated to
